Updated Neurocloud platform simultaneously analyses PET, MRI and SPECT images
Specialist in AI solutions for advanced neuroimaging analysis Qubio demonstrated the latest version of its Neurocloud platform at the European Congress of Clinical Neuroimaging 2025 in Madrid, Spain.
The new version of Neurocloud features a completely redesigned, more intuitive and user-friendly interface, ensuring seamless integration into clinical workflows and enhancing user experience. Additionally, Neurocloud 2025 introduces an automated multimodal ecosystem capable of simultaneously analysing PET, MR and SPECT images, improving diagnostic accuracy and efficiency in evaluating neurodegenerative diseases.
A significant advancement in this version is the centiloid scale for amyloid imaging that provides a more precise and reproducible quantification of cerebral amyloid burden, critical for the diagnosis and monitoring of Alzheimer’s patients treated with recently approved drugs, says Qubio.
Picture: Qubio team members demonstrate the latest version of its Neurocloud platform.
Read this report on page 21 of the May issue of RAD Magazine.
